MedTrace Logo

Effect of Community Pharmacist Intervention on Adherence to Long-Term Medications

NCT02604901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1091

Last updated 2015-11-16

No results posted yet for this study

Summary

The 4-arm factorial design RCT tested the impact of a behavioral intervention (SBI or BI), a reminder device (Pillbox), and the combination of the two on adherence in adult patients who filled a prescription for oral medications to treat diabetes or hyperlipidemia.

Conditions

  • Medication Adherence

Interventions

BEHAVIORAL

Screening and Brief Intervention (BI)

Rite Aid® pharmacists screened patients at the time of the initial fill with the Adherence Estimator™ and using the screening results, provided the behavioral intervention, Brief Intervention using motivational interviewing principles based on POLAR\*S (BI). BI was considered an active intervention method.

BEHAVIORAL

Pill Box (PB)

Rite Aid® pharmacists provided patients with a Pill Box (PB) and information about their medications. However, pharmacists did not use motivational interviewing principles for engaging patients in direct interventions to modify behavior. PB was considered a passive intervention method.

Sponsors & Collaborators

  • Rite Aid Corp.

    collaborator INDUSTRY

  • RTI International

    collaborator OTHER

  • Pharmacy Quality Alliance

    collaborator OTHER

  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY

  • University of Pittsburgh

    lead OTHER

Principal Investigators

  • Janice L Pringle, PhD · University of Pittsburgh

  • Newell McElwee, PharmD, MSPH · Merck Sharp & Dohme LLC

Study Design

Allocation
RANDOMIZED
Masking
NONE
Model
FACTORIAL

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-06-30
Primary Completion
2014-07-31
Completion
2014-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02604901 on ClinicalTrials.gov